Skip to main content
Clinical Trials/PACTR202001818109834
PACTR202001818109834
Completed
Phase 4

Resistance Training impact on lean mass and Muscle Strength in Pancreatic Cancer Cachexia: A Randomised Controlled Trial

FATMA ALZAHRAA H. KAME0 sites40 target enrollmentJanuary 12, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Cancer
Sponsor
FATMA ALZAHRAA H. KAME
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

A relative short duration of resistant exercises improved considerably lean body mass, muscle strength and functional performance in pancreatic cancer cachexia. The exercise regimen has been well tolerated and should be strongly suggested for these patients as an important support measure to counteract cachexia.

Registry
who.int
Start Date
January 12, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
FATMA ALZAHRAA H. KAME

Eligibility Criteria

Inclusion Criteria

  • resectable or non\-resectable PC \[stages I–IV].
  • adults \[\= 20 years of age].
  • compliance with international guidelines for cancer cachexia diagnosis, including:
  • weight loss over the past 6 months \> 5 percent.
  • weight loss \> 2 percent in patients with body mass index \[BMI] of less than 20 kg / m2,
  • evidence of sarcopenia with a weight loss of more than 2 percent.

Exclusion Criteria

  • any musculoskeletal disorders
  • any neurological disorders
  • the hematological capacity was severely impaired,
  • uncontrolled hypertension,
  • heart failure and unknown arrhythmia,
  • severe renal impairment,
  • diminished ability to stand or walk,
  • any other comorbidities that may hinder exercise.

Outcomes

Primary Outcomes

Not specified

Similar Trials